Topics

Latest "dATS Cumulative Irritation Sensitization" News Stories

15:53 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "dATS Cumulative Irritation Sensitization" found in our extensive news archives from over 250 global news sources.

More Information about dATS Cumulative Irritation Sensitization on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about dATS Cumulative Irritation Sensitization for you to read. Along with our medical data and news we also list dATS Cumulative Irritation Sensitization Clinical Trials, which are updated daily. BioPortfolio also has a large database of dATS Cumulative Irritation Sensitization Companies for you to search.

Showing "dATS Cumulative Irritation Sensitization" News Articles 1–25 of 293

Thursday 20th February 2020

Efficient Assistance, YITU AI Aids Epidemic Prevention and Control of COVID-19 Outbreak

Since the outbreak of COVID-19, Yitu Healthcare responded quickly and launched an operation of multiple departments. The main R & D team sacrificed their vacations, worked around the clock for several consecutive days and finally completed the development of the Intelligent Evaluation System of Chest CT for COVID-19 in a very short period of time. The system was launched during the Chinese Sp...


Wednesday 19th February 2020

Survival Guide for Allergy Season: Latest Tips According to Shirin Peters, M.D. With Bethany Medical Clinic

According to the American College of Allergy, Asthma & Immunology, allergies affect 50 million people each year and the winter can be a breeding ground for mold, dust mites, and animal dander due to heat, and lack of ventilation. “During the winter months and leading into spring, many suffer from seasonal allergies that continue to persist if not treated appropriately. I often recommend t...

Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs

Five Prime receives $5 million upfront payment and is eligible to receive up to a combined total of $525 million in future milestone payments for the first two ADC product candidates Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage


Hair Testosterone Concentrations and Emotional Reactivity

This study investigates the relationship between hair testosterone concentration--an index of long-term cumulative testosterone levels--and emotion processing neuroimaging data. Social Cognitive and Affective Neuroscience

Gerresheimer AG: Gerresheimer sets foundation for profitable growth in 2019

DGAP-News: Gerresheimer AG / Key word(s): Annual Results 19.02.2020 / 07:31 The issuer is solely responsible for the content of this announcement. Gerresheimer sets foundation for profitable growth in 2019 - Foundation for sustainable and profitable growth laid in 2019: Annual revenue growth in the mid-single-digit percentage range targeted for 2020 and subsequent years...

Tuesday 18th February 2020

Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH-Organized Medical Countermeasures Meeting

- First results from ocular injury program to treat damage from sulfur mustard gas - - Announces $1 million funding from the National Eye Institute for continuation of program development - Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced a poster presentation at the upcoming National Institutes of Health (...

FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes’ Columbia, Mo. Facility

− State-of-the art equipment to increase production efficiency and output for U.S.-based Mo-99 supply − NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Co...

Monday 17th February 2020

Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch

Now available in the U.S., Pataday® Once Daily Relief is the first and only eye drop to provide all day allergy itch relief without a prescription1,2 Approximately 66 million Americans who suffer from eye allergies will now have OTC access to long-lasting, prescription-strength relief that works in minutes1,2, 4-7 National retail availability and robust media campaign to begin March 2 in ti...

Sunday 16th February 2020

Global Artificial Tears Market Data Survey Report 20152025 [Published by HeyReport] Prices from USD $1275

SummaryArtificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca dry eyes. They are also used to moisten contact lenses and in eye examinations.The global Artificial Tears market will reach xxx Million USD in 2020 with CAGR xx% 20202025. The main contents of the report including:Global market size and f...

Thursday 13th February 2020

Landmark Health and Blue Cross & Blue Shield of Rhode Island Collaborate to Bring High-touch, In-home Medical Care to Complex Patients

Landmark Health and its affiliated medical group (Landmark) and Blue Cross & Blue Shield of Rhode Island (BCBSRI) have come together to enhance access to care and coordination for BCBSRI Medicare Advantage members managing multiple chronic conditions. Landmark’s physician-led medical group gives patients access to a team of speci

Wednesday 12th February 2020

[Comment] What are the risks of COVID-19 infection in pregnant women?

Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. As of Feb 11, 2020, the cumulative number of confirmed cases in mainland China has reached 38 800, with 4740 (12·2%) cured cases and 1113 (2·9%) deaths; additionally, there have been 16 067 suspected cases so far.1 All 31 provinces in mainland China have ...

Tuesday 11th February 2020

Blue Earth Diagnostics Announces Upcoming Presentations from FALCON Study of Axumin® (Fluciclovine F18) PET/CT Impact on Clinical Management of Recurrent Prostate Cancer

− ASCO 2020 Genitourinary Cancers Symposium and Radiation Oncology Summit: ACRO 2020 − Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announced upcoming presentations of additional analyses from the FALCON clinical trial (NCT02578940) of Axumin® (fluciclovine F18) injection), which evaluated its impact on the management of patients with recurrent pr...

Mycovia Pharmaceuticals Initiates Extension Clinical Studies to Further Evaluate Long-Term Efficacy of Oteseconazole (VT-1161) in Patients with Recurrent Vulvovaginal Candidiasis

Observational studies open to U.S. patients enrolled in Phase 3 VIOLET clinical trials who remain free of disease after 48 weeks Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced it has initiated extension studies as part of its ongoing Phase 3 VIOLET clinical trials for oteseconazole (VT-1161). Mycovia is developing oteseconazole, an oral antifungal product candidate, for the treat...

Monday 10th February 2020

Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules

Lined up all the sold Newmacor capsules end-to-end would reach 1,043km Future target growth is to reach blockbuster levels and exceed 10 billion KRW SEOUL, South Korea, Feb. 10, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) is celebrating the 5th anniversary of the launch of its first generic hypertriglyceridemia 

Skysong Innovations Completes Licensing Agreement with ASU Spinout OncoMyx Therapeutics

Immunotherapy company backed by $25 million in Series A financing is developing cancer treatments based on novel ASU technology PHOENIX (PRWEB) February 10, 2020 OncoMyx Therapeutics, an Arizona State University (ASU) spinout and privately-held oncolytic immunotherapy company founded on the myxoma virus (MYXV) platform, has finalized a licensing agreement with Skysong Innovations, ASU’s technol...

Sunday 9th February 2020

Study: It's devastatingly common for African mothers to experience child loss

(University of Southern California) University of Southern California and University of Chicago sociologists propose new indicators to estimate how common it is for mothers to have experienced the death of a child. In contrast to traditional measures of infant and child mortality, their results capture the cumulative impact of child loss through a mother's lifetime.

Thursday 6th February 2020

20172025 World Dishwashing Liquid Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryDishwashing liquid, known as dishwashing soap, dish detergent and dish soap, is a detergent used to assist in dishwashing. It is usually a highlyfoaming mixture of dyskinesia with low skin irritation for cleaning washing, glasses, plates, cutlery, and cooking utensils in a sink or bowl. In addition to its primary use, dishwashing liquid also informal applications, such as for creating bubbl...

Octapharma demonstrates commitment to improving haemophilia A treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

Octapharma had a prominent role as a Sponsor of the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) Congress this week, which takes place in The Hague, The Netherlands, from February 5–7, 2020. Octapharma’s activities at the Congress included a scientific symposium that focused on addressing the needs of patients with haemophilia A. The symposiu...

Monday 3rd February 2020

Can-Fite Completes 50% Patient Enrollment in Phase III Rheumatoid Arthritis Study & Implements Interim Analysis

Interim analysis by IDMC intended to improve study’s efficiency and accelerate path towards regulatory approval Piclidenoson evaluated as first line therapy and replacement for the current standard of care, methotrexate, the most widely used drug for rheumatoid arthritis Rheumatoid arthritis is forecast to be $47 billion market in 2024

Friday 31st January 2020

4SC - Resminostat and RESMAIN Study Update

DGAP-News: 4SC AG / Key word(s): Study 31.01.2020 / 07:30 The issuer is solely responsible for the content of this announcement. 4SC - Resminostat and RESMAIN Study Update Independent Data Safety Monitoring Board recommends RESMAIN study to continue without modification following review of cumulative safety data from first 150 patients enrolled RESMAIN - a pivotal st...

Thursday 30th January 2020

AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update

U.S. RECELL® System product sales of A$4.66M for fiscal second quarter AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal second quarter ended 31 December 2019 today in its Appendix 4C - Quarterly Cash Flow Report filed with...

Innovative Industrial Properties Announces Tax Treatment of 2019 Distributions

Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) today announced the tax treatment of its 2019 distributions as follows: Security Description: Common Stock CUSIP: 45781V101 Ticker Symbol: IIPR

Tuesday 28th January 2020

Southwestern Health Resources Accountable Care Network Listed No. 1 in U.S. for Medicare Savings for Second Straight Year

The Centers for Medicare & Medicaid Services (CMS) announced that the Southwestern Health Resources Accountable Care Network (SWHR) saved more than $37 million in 2018. These generated savings place it at the top of organizations participating in the CMS Next Generation Accountable Care Organization (ACO) Model. SWHR has saved more than $67 million since joining the Next Generation ACO Model ...

Sunday 26th January 2020

CPAP Store USA's Press Release: ResMed Launches AirFit F30i, Its First Tube-up Full Face CPAP Mask

CPAP Store USA, an accredited and an authorized ResMed dealer announces the launch of the AirFit F30i, Its First Tube-up Full Face ResMed CPAP Mask. The CPAPers who use full face CPAP masks can now choose between a tube-up or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam versus silicone cushion. AirFit F30i’s tube-up design makes i...

20172025 World Headless Compression Screws Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryHeadless Compression Screws are selfdrilling, selftapping headless screws that allow surgeon controlled compression and a simplified technique. The headless design helps minimize hardware prominence and soft tissue irritation.This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report c...


Quick Search

News Quicklinks